Anti-pig xenogeneic response by T CD4+ human lymphocytes.

被引:0
|
作者
Watier, H [1 ]
Vallée, I [1 ]
Bardos, P [1 ]
Lebranchu, Y [1 ]
机构
[1] Univ Tours, UPRESJE Interact Hote Greffon 1992, F-37032 Tours, France
来源
PATHOLOGIE BIOLOGIE | 2000年 / 48卷 / 04期
关键词
dendritic cells; direct recognition; endothelium; indirect recognition; xenogeneic T cell response;
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
When considering the hypothesis of xenotransplantation. and if it becomes possible to control hyperacute and delayed vascular rejection, the recognition of porcine graft by human T CD4(+) lymphocytes could still constitute a very important barrier. The direct recognition of porcine MHC class II molecules (SLA-DR and SLA-DQ) by human TCR has been demonstrated in vitro. It is accompanied by a proliferative lymphocytic response, as co-stimulatory molecules are able to interact across the species barrier. In vivo, this type of recognition only applies to porcine cells with antigen-presenting functions, mainly the graft dendritic cells which emigrate into the recipient lymphoid organs. The other recognition pathway is indirect, whereby the recipient dendritic cells capture porcine xenoantigens in the graft, then process and present them to the lymphocytes in the lymphoid organs. This indirect pathway can be shown in vitro by utilizing porcine MHC class Ii-negative endothelial cells. In this model, human purified T CD4(+) lymphocyte proliferation is tightly dependent on the presence of human antigen-presenting cells and their HLA class II molecules. As the xenogenic peptides all differ from self peptides, the indirect T-cell response will be very strong and probably difficult to control. (C) 2000 Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:372 / 376
页数:5
相关论文
共 50 条
  • [1] The role of human T cells in human anti-pig xenogeneic cellular responses
    Xu, H
    Fagoaga, O
    Gundry, SR
    Bailey, LL
    [J]. TRANSPLANTATION PROCEEDINGS, 2000, 32 (05) : 952 - 953
  • [2] Human Anti-Pig Xenogeneic T-Cell Response in the Absence of HD Antigen.
    Shah, A.
    Sidner, R.
    Paris, L.
    Estrada, J.
    Tector, A.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 373 - 373
  • [3] CD4+ cells play a major role in xenogeneic human anti-pig cytotoxicity through the Fas/Fas ligand lytic pathway
    Yi, SN
    Feng, XM
    Wang, Y
    Kay, TWH
    Wang, Y
    O'Connell, PJ
    [J]. TRANSPLANTATION, 1999, 67 (03) : 435 - 443
  • [4] T cells and autoimmunity:: Immunoregulation by CD40 expressed on CD4+ T lymphocytes.
    Munroe, ME
    Bishop, GA
    [J]. CLINICAL IMMUNOLOGY, 2005, 115 : S222 - S222
  • [5] Regulation of EMMPRIN and MMP-9 expression by CD4+ T lymphocytes.
    Langley, RS
    Massey, HM
    Moots, RJ
    Pazmany, L
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S62 - S62
  • [6] Baboon CD4+ CD25+ T regulatory cells inhibit anti porcine xenogeneic response
    Porter, Cynthia
    Bloom, Eda T.
    Horvath-Arcidiacono, Judith
    Horvath, Keith A.
    Mohiuddin, Muhammad M.
    [J]. CIRCULATION, 2006, 114 (18) : 709 - 710
  • [7] Differential regulation of perforin expression in CD4+ and CD8+ cytotoxic T lymphocytes.
    Niiya, H
    Lei, J
    Sakai, I
    Azuma, T
    Uchida, N
    Yakushijin, Y
    Hato, T
    Fujita, S
    Yasukawa, M
    [J]. BLOOD, 2004, 104 (11) : 49B - 49B
  • [8] Xenogeneic human anti-pig cytotoxicity mediated by activated natural killer cells
    Seebach, JD
    Yamada, K
    McMorrow, IM
    Sachs, DH
    DerSimonian, H
    [J]. XENOTRANSPLANTATION, 1996, 3 (02) : 188 - 197
  • [9] Inhibition of human anti-pig T cell response by Anti-CD2, Anti-CD40L, and CTLA4-Ig: A comparative study
    Xu, Y
    Ryan, D
    Wu, C
    Bazin, H
    Latinne, D
    White-Scharf, ME
    Thall, AD
    [J]. TRANSPLANTATION PROCEEDINGS, 2000, 32 (05) : 926 - 926
  • [10] Differential effects of salicylates on IL-4 and IL-2 expression in human CD4+ T lymphocytes.
    Cianferoni, A
    Schroeder, JT
    Vierucci, A
    Lichtenstein, LM
    Georas, SN
    Casolaro, V
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (01) : S240 - S240